Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 101–200 of 2,099
Chen, Y. Q., Pottanat, T. G., Siegel, R. W., Ehsani, M., Qian, Y.-W., Zhen, E. Y., Regmi, A., Roell, W. C., Guo, H., Luo, M. J., et al. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000781 · Cited by 147
Meng, Q., Qi, X., Fu, Y., Chen, Q., Cheng, P., Yu, X., Sun, X., Wu, J., Li, W., Zhang, Q., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112326 · Cited by 145
Maina, J. G., Balkhiyarova, Z., Nouwen, A., Pupko, I., Ulrich, A., Boissel, M., Bonnefond, A., Froguel, P., Khamis, A., Prokopenko, I., et al. (2023) · Diabetes Care · doi:10.2337/dc22-2373 · Cited by 163
“IRS1 is a key signaling molecule associated with insulin resistance (34), a condition linked to both type 2 diabetes and depression (35).”
BackgroundStefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes
Gar, C., Rottenkolber, M., Prehn, C. P., Adamski, J., Seißler, J., & Lechner, A. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1414143 · Cited by 153
Transcriptomic analyses reveal rhythmic and CLOCK-driven pathways in human skeletal muscle
Perrin, L., Loizides-Mangold, U., Chanon, S., Gobet, C., Hulo, N., Isenegger, L., Weger, B. D., Migliavacca, E., Charpagne, A., Betts, J. A., et al. (2018) · eLife · doi:10.7554/elife.34114 · Cited by 139
“Muscle clock alteration impairs glucose uptake in response to insulin Skeletal muscle is responsible for 70–80% of insulin-stimulated glucose uptake (DeFronzo and Tripathy, 2009).”
BackgroundBowden Davies, K. A., Sprung, V. S., Norman, J. A., Thompson, A., Mitchell, K. L., Halford, J. C. G., Harrold, J. A., Wilding, J. P. H., Kemp, G. J., & Cuthbertson, D. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4603-5 · Cited by 138
Lambernd, S., Taube, A., Schober, A., Platzbecker, B., Görgens, S. W., Schlich, R., Jeruschke, K., Weiss, J., Eckardt, K., & Eckel, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2454-z · Cited by 166
“The activation of inflammatory pathways leads to insulin resistance [10] in peripheral tissues such as skeletal muscle and adipose tissue, constituting an early defect in the pathogenesis of type 2 diabetes [11].”
BackgroundCedernaes, J., Schönke, M., Westholm, J. O., Mi, J., Chibalin, A., Voisin, S., Osler, M., Vogel, H., Hörnaeus, K., Dickson, S. L., et al. (2018) · Science Advances · doi:10.1126/sciadv.aar8590 · Cited by 137
Giuliani, G., Rosina, M., & Reggio, A. (2021) · FEBS Journal · doi:10.1111/febs.16080 · Cited by 159
Lee, D. H., Keum, N., Hu, F. B., Orav, E. J., Rimm, E. B., Willett, W. C., & Giovannucci, E. L. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0433-5 · Cited by 154
Imidacloprid Promotes High Fat Diet-Induced Adiposity and Insulin Resistance in Male C57BL/6J Mice
Sun, Q., Xiao, X., Kim, Y., Kim, D., Yoon, K. S., Clark, J. M., & Park, Y. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04322 · Cited by 142
“56 In muscle, GLUT4 is the main glucose transporter responsible for glucose uptake in response to insulin stimulation.”
Qiao, Y.-S., Chai, Y.-H., Gong, H.-J., Zhuldyz, Z., Stehouwer, C. D. A., Zhou, J.-B., & Simó, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.782391 · Cited by 132
“Second, poor blood glucose control causes many metabolic abnormalities (10), such as the activation of apoptosis triggered by TNF-a (48) and impaired muscle mitochondrial oxidative capacity (49), thereby contributing to muscle cell damage (10).”
BackgroundRelative muscle mass and the risk of incident type 2 diabetes: A cohort study
Hong, S., Chang, Y., Jung, H. S., Yun, K. E., Shin, H. C., & Ryu, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188650 · Cited by 158
Wang, T., Li, M., Zeng, T., Hu, R., Xu, Y., Xu, M., Zhao, Z., Chen, Y., Wang, S., Lin, H., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0202 · Cited by 141
Celis-Morales, C. A., Petermann, F., Hui, L., Lyall, D. M., Iliodromiti, S., McLaren, J., Anderson, J., Welsh, P., Mackay, D. F., Pell, J. P., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0921 · Cited by 130
Ferulic acid improves lipid and glucose homeostasis in high‐fat diet‐induced obese mice
Naowaboot, J., Piyabhan, P., Munkong, N., Parklak, W., & Pannangpetch, P. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12514 · Cited by 135
“Dyslipidaemia and lipid accumulation in the liver are found in insulin resistance and obesity.(22,23) PPARa is a well-known nuclear receptor in the regulation of hepatic lipid metabolism by stimulating the transcription of PPARa regulated genes such as CPT1.”
BackgroundThe role of mitochondria-associated membranes in cellular homeostasis and diseases
Perrone, M., Caroccia, N., Genovese, I., Missiroli, S., Modesti, L., Pedriali, G., Vezzani, B., Vitto, V. A. M., Antenori, M., Lebiedzińska, M., et al. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.11.002 · Cited by 141
Zhao, Z., Barcus, M., Kim, J., Lum, K., Mills, C., & Lei, X. G. (2016) · Journal of Nutrition · doi:10.3945/jn.116.229955 · Cited by 136
“Because muscle represents the largest insulin-responsive tissue in the body (60), downregulation of INSR and upregulation of the mTOR-S6 pathway (49) might impair insulin signaling, contributing to the hyperinsulinemia that is an early event of insulin resistance.”
Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review
Sharma, B., & Dabur, R. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666181129095309 · Cited by 125
Villalobos-Labra, R., Subiabre, M., Toledo, F., Pardo, F., & Sobrevía, L. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.001 · Cited by 138
Sarcopenia and fatty liver disease
Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 134
Lacroix, I. M. E., & Li‐Chan, E. C. Y. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300223 · Cited by 145
Hamer, M., Batty, G. D., & Kivimaki, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.124 · Cited by 121
Metabolic Functions of Myostatin and GDF11
C. McPherron, A. (2010) · Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry · doi:10.2174/187152210793663810 · Cited by 124
“Because skeletal muscle takes up more glucose in response to insulin than any other tissue [56], improving skeletal muscle insulin sensitivity is an important target for increasing whole body sensitivity to insulin and preventing the onset of frank diabetes.”
BackgroundThe Source of Glycolytic Intermediates in Mammalian Tissues
TeSlaa, T. A., Bartman, C., Jankowski, C. S. R., Zhang, Z., Xu, X., Xing, X., Wang, L., Lu, W., Hui, S. T., & Rabinowitz, J. D. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.020 · Cited by 129
“Muscle is a primary site of insulin resistance in diabetes, and our results suggest that red muscles play a central role in direct catabolism of circulating glucose (DeFronzo and Tripathy, 2009; Kelley et al., 2002; Rothman et al., 1995).”
BackgroundDefects in Insulin Secretion and Action in the Pathogenesis of Type 2 Diabetes Mellitus
Tripathy, D., & Chávez, A. O. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0115-5 · Cited by 147
“During euglycemic hyperinsulinemia (80–100 μU/mL), hepatic glucose production is suppressed, and about 75% to 80% of glucose uptake occurs in skeletal muscle [ 3 ].”
BackgroundSelf-citationWu, H., Zhang, Y., Cao, C., Hu, X., Fang, M., Yao, Y., Li, J., Chen, G., Jiang, P., Zhang, S., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037216 · Cited by 127
ter Horst, K. W., Schene, M. R., Holman, R., Romijn, J. A., & Serlie, M. J. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137786 · Cited by 135
Resistance training to improve type 2 diabetes: working toward a prescription for the future
Pesta, D. H., Goncalves, R. L. S., Madiraju, A. K., Strasser, B., & Sparks, L. M. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0173-7 · Cited by 120
“Skeletal muscle is responsible for ~80% of insulinmediated glucose uptake in the postprandial state [14], and uptake is markedly blunted in individuals with T2D [15].”
BackgroundSarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population?
Scott, D., Courten, B., & Ebeling, P. R. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00446 · Cited by 119
Hulett, N. A., Scalzo, R. L., & Reusch, J. E. B. (2022) · Nutrients · doi:10.3390/nu14030647 · Cited by 157
“Skeletal muscle is a primary target of systemic glucose disposal; thus, interference in skeletal muscle glucose transport is sufficient to induce whole-body insulin resistance [30,31].”
BackgroundObesity and cardiovascular disease: an ESC clinical consensus statement
Koskinas, K. C., Craenenbroeck, E. M. V., Antoniades, C. A., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae279 · Cited by 148
Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 129
Enhanced Skeletal Muscle for Effective Glucose Homeostasis
Yang, J. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00005-3 · Cited by 154
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 143
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
Armandi, A., Rosso, C., Caviglia, G. P., & Bugianesi, E. (2021) · Metabolites · doi:10.3390/metabo11030155 · Cited by 126
“In the insulin-resistant condition, insulin-mediated glucose uptake in the postprandial state is impaired [3].”
Backgroundβ−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Wess, J., Oteng, A., Rivera‐Gonzalez, O., Gurevich, E. V., & Gurevich, V. V. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000302 · Cited by 132
Granic, A., Suetterlin, K., Shavlakadze, T., Grounds, M. D., & Sayer, A. A. (2023) · Clinical Science · doi:10.1042/cs20230319 · Cited by 136
“Skeletal muscle is responsible for 80% of postprandial glucose uptake [141], thus a right-shift in this relationship may account for a significant proportion of insulin resistance [142].”
BackgroundFructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues
Baena, M., Sangüesa, G., Dávalos, A., Latasa, M.-J., Sala‐Vila, A., Sánchez, R. M., Roglans, N., Laguna, J. C., & Alegret, M. (2016) · Scientific Reports · doi:10.1038/srep26149 · Cited by 118
Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion
Hong, S., Zhou, W., Fang, B., Lu, W., Loro, E., Damle, M., Ding, G., Jager, J., Zhang, S., Zhang, Y., et al. (2017) · Nature Medicine · doi:10.1038/nm.4245 · Cited by 110
Phenolic Profile, Antioxidant, and Antidiabetic Potential Exerted by Millet Grain Varieties
Ofosu, F. K., Elahi, F., Daliri, E. B., Chelliah, R., Ham, H.-J., Kim, J., Han, S., Hur, J.-H., & Oh, D. (2020) · Antioxidants · doi:10.3390/antiox9030254 · Cited by 133
“Excessive ROS-induced oxidative stress is one of the main mechanisms of the progression of diabetes causing cellular damage and resulting in various gene expression dysregulations which lead to impaired insulin secretion and insulin signaling [1,3,4].”
BackgroundShu, X., Wu, L., Khankari, N. K., Shu, X., Wang, T. J., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Milne, R. L., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy201 · Cited by 120
Minireview: New Molecular Mediators of Glucocorticoid Receptor Activity in Metabolic Tissues
Patel, R., Williams-Dautovich, J., & Cummins, C. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1062 · Cited by 108
Steneberg, P., Lindahl, E., Dahl, U., Lidh, E., Straseviciene, J., Backlund, F., Kjellkvist, E., Berggren, E., Lundberg, I., Bergqvist, I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99114 · Cited by 108
Hançer, N. J., Qiu, W., Cherella, C., Li, Y., Copps, K. D., & White, M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554162 · Cited by 107
Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis
Mirhosseini, N. Z., Vatanparast, H., Mazidi, M., & Kimball, S. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00472 · Cited by 126
“This is different from the fed-state HOMA-IR representing peripheral insulin resistance or failure of glucose uptake in muscle tissues [85].”
BackgroundBatista, T. M., Jayavelu, A. K., Wewer Albrechtsen, N. J., Iovino, S., Lebastchi, J., Pan, H., Dreyfuss, J. M., Krook, A., Zierath, J. R., Mann, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.007 · Cited by 107
“, 1990), which is of critical relevance since this tissue is the primary site of glucose disposal when insulin levels are high as in the post-prandial state or during an euglycemic-hyperinsulinemic clamp (DeFronzo and Tripathy, 2009; Kowalski and Bruce, 2014).”
BackgroundTaheri, R., Mokhtari, Y., Yousefi, A., & Bashash, D. (2024) · Cell Biology International · doi:10.1002/cbin.12189 · Cited by 126
“The primary function of insulin in regulating skeletal muscle metabolism is promoting glucose uptake and glycogen synthesis through the PI3K/Akt signaling pathway (DeFronzo & Tripathy, 2009).”
Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice
Benetti, E., Mastrocola, R., Chiazza, F., Nigro, D., D’Antona, G., Bordano, V., Fantozzi, R., Aragno, M., Collino, M., & Minetto, M. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189707 · Cited by 115
Sarcopenia and Diabetes: Two Sides of the Same Coin
Landi, F., Onder, G., & Bernabei, R. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.004 · Cited by 106
AMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 122
“In the natural history ofper se DeFronzo and Tripathy 2009 Unger 1995 type 2 diabetes, pancreatic -cells initially compensate for insulin resistance by increasing insulin secretion, but with time, progressive β β -cell failure leads to insulin deficiency, and hyperglycaemia ensues ( ).”
BackgroundPerrin, L., Loizides-Mangold, U., Skarupelova, S., Pulimeno, P., Chanon, S., Robert, M., Bouzakri, K., Modoux, C., Roux-Lombard, P., Vidal, H., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.009 · Cited by 104
“It is responsible for 70e80% of insulin-stimulated glucose uptake and therefore representing the most important site of insulin resistance in T2D patients [12].”
BackgroundMetabolic Inflammation-Differential Modulation by Dietary Constituents
Lyons, C., Kennedy, E., & Roche, H. (2016) · Nutrients · doi:10.3390/nu8050247 · Cited by 104
“Skeletal muscle is responsible for approximately 80% of the glucose uptake in the body following insulin stimulation [66].”
BackgroundKelstrup, L., Damm, P., Mathiesen, E. R., Hansen, T., Vaag, A. A., Pedersen, O., & Clausen, T. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1536 · Cited by 104
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.004 · Cited by 123
“Peripheral insulin resistance is the central pathogenesis of major metabolic disorders, endocrine, cardiovascula r, hepatic disorders, infections and cancer among o thers and insulin resistance in skeletal muscle impacts whole b dy glucose homeostasis [1].”
Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21
Guridi, M., Tintignac, L. A., Lin, S., Kupr, B., Castets, P., & Rüegg, M. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab3715 · Cited by 99
“Several lines of evidence indicate that alterations of the normal muscle function, as for example in muscular dystrophies, obesity or diabetes, can affect the metabolism at the whole-body level (1, 2).”
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Peña‐Oyarzún, D., Bravo, R., Díaz‐Vegas, A., Aleman, L., Chiong, M., García, L., Claudia Bambs, S., Troncoso, R., Cifuentes, M., Morselli, E., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.084 · Cited by 114
Cellular and Molecular Mechanisms of Insulin Resistance
Chandrasekaran, P., & Weiskirchen, R. (2024) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-024-00056-3 · Cited by 142
“The skeletal muscle plays an important role in insulin-stimulated glucose consumption, which means that muscular IR can have various effects in overall body metabolism [29].”
Patel, S. V. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.02.010 · Cited by 109
Kitessa, S., & Abeywardena, M. (2016) · Nutrients · doi:10.3390/nu8080466 · Cited by 98
“Skeletal muscle IR is thus considered the initiating or primary defect [7] that can be detected decades ahead of the β-cell failure and hyperglycaemia.”
BackgroundHypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, E., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 97
Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy
Parasoglou, P., Rao, S., & Slade, J. M. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.05.001 · Cited by 117
“IMAT infiltration in large muscle groups of the lower extremity is a particularly important etiologic factor in the onset and progression of type 2 DM and its complications due to its hormonal and structural influences on skeletal muscle, which is responsible for 90% of peripheral glucose uptake.(151) IMAT can be quan…”
BackgroundJain, S. K., Parsanathan, R., Achari, A. E., Kanikarla-Marie, P., & Bocchini, J. A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7462 · Cited by 97
“Muscle is a major site of glucose metabolism and maintenance of glucose homeostasis (12).”
BackgroundMazibuko, S. E., Muller, C. J. F., Joubert, E., de Beer, D., Johnson, R., Opoku, A. R., & Louw, J. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.03.018 · Cited by 114
Khan, I. M., Dai Perrard, X.-Y., Perrard, J. L., Mansoori, A., Wayne Smith, C., Wu, H., & Ballantyne, C. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.011 · Cited by 97
“Improved glucose and insulin tolerance in HFD-fed TCRb / mice may primarily reflect reduced inflammation in skeletal muscle, the major tissue responsible for glucose uptake [34,35].”
Lin, T., Peng, C., Hung, S., & Tarng, D. (2017) · Kidney International · doi:10.1016/j.kint.2017.08.025 · Cited by 110
Kim, G., Lee, S., Jun, J. E., Lee, Y., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0659-2 · Cited by 110
“Because skeletal muscle is the major site of insulin-mediated glucose utilization (up to 80% in the postprandial state), losses in skeletal muscle mass may lead to metabolic impairments [12].”
BackgroundModification of Insulin Sensitivity and Glycemic Control by Activity and Exercise
ROBERTS, C. K., LITTLE, J. P., & THYFAULT, J. P. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318295cdbb · Cited by 95
“As mentioned previously, it is well known that skeletal muscle plays a major role in whole-body glucose disposal, and insulin resistance in skeletal muscle is recognized as a key contributor to impaired glucose control in T2D (23).”
BackgroundZhang, X., Dong, L., Jia, X., Liu, L., Chi, J., Huang, F., Ma, Q., Zhang, M., & Zhang, R. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c00584 · Cited by 99
Laurens, C., Bourlier, V., Mairal, A., Louche, K., Badin, P.-M., Mouisel, E., Montagner, A., Marette, A., Tremblay, A., Weisnagel, J. S., et al. (2016) · Scientific Reports · doi:10.1038/srep38310 · Cited by 93
SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK
Cui, X., Yao, L., Yang, X., Gao, Y., Fang, F., Zhang, J., Wang, Q., & Chang, Y. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00122.2017 · Cited by 94
Koh, J.-H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., et al. (2019) · Diabetes · doi:10.2337/db19-0088 · Cited by 92
“Skeletal muscle insulin resistance (IR) is a cardinal feature of T2DM and it is often present years prior to T2DM onset (2).”
BackgroundThe regulation of PKA signaling in obesity and in the maintenance of metabolic health
London, E., & Stratakis, C. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108113 · Cited by 104
Putti, R., Migliaccio, V., Sica, R., & Lionetti, L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00426 · Cited by 91
“…fission, lard, fish oil, omega-3 fatty acids INTRODUCTION Skeletal muscle seems to play a central role in whole body insulin resistance (IR) and metabolic syndrome associated with high fat (HF) feeding, obesity and aging (see Corpeleijn et al., 2009; DeFronzo and Tripathy, 2009; Lark et al., 2012).”
BackgroundRen, Q., Chen, S., Chen, X., Niu, S., Yue, L., Pan, X., Li, Z., & Chen, X. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s381546 · Cited by 91
“The LBM is mainly composed of skeletal muscle, and lower skeletal muscle mass can lead to poorer glycemic control because it is the main site of glucose processing.(13) Furthermore, the reduction in muscle mass is synergistically accompanied by the accumulation of fat mass in T2DM, leading to the socalled “SO”.”
BackgroundFOXO1 Mediates Vitamin D Deficiency–Induced Insulin Resistance in Skeletal Muscle
Chen, S., Villalta, S. A., & Agrawal, D. K. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2729 · Cited by 91
“Insulin resistance in muscle has been demonstrated to be a primary characteristic, pathophysiological defect in the majority of patients with DM2.”
InfluentialGarneau, L., & Aguer, C. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.006 · Cited by 91
Erion, D. M., Park, H., & Lee, H. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.3.268 · Cited by 101
The role of stress kinases in metabolic disease
Nikolić, I., Leiva, M., & Sabio, G. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00418-5 · Cited by 97
Greene, N. P., Lee, D. E., Brown, J. L., Rosa, M. E., Brown, L. A., Perry, R. A., Henry, J. N., & Washington, T. A. (2015) · Physiological Reports · doi:10.14814/phy2.12470 · Cited by 89
“12470 Physiol Rep, 3 (7), 2015, e12470, doi 10.14814/phy2.”
BackgroundInfluentialCLOCK and BMAL1 Regulate Muscle Insulin Sensitivity via SIRT1 in Male Mice
Liu, J., Zhou, B., Yan, M., Huang, R., Wang, Y., He, Z., Yang, Y., Dai, C., Wang, Y., Zhang, F., et al. (2016) · Endocrinology · doi:10.1210/en.2015-2027 · Cited by 88
“Skeletal muscle is the predominant site of insulin-mediated glucose uptake in the postprandial state, and skeletal muscle insulin resistance is an early therapeutic target in young insulin resistant individuals (21, 22).”
Obesity Alters the Muscle Protein Synthetic Response to Nutrition and Exercise
Beals, J. W., Burd, N. A., Moore, D. R., & van Vliet, S. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00087 · Cited by 88
“For example, impaired insulin sensitivity is a fundamental characteristic of Type 2 diabetes (19).”
BackgroundDissecting the role of AMP-activated protein kinase in human diseases
Li, J., Zhong, L., Wang, F., & Zhu, H. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.12.003 · Cited by 94
Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
Chakravarthy, M. V., Siddiqui, M. S., Forsgren, M. F., & Sanyal, A. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592373 · Cited by 88
“Yet, few if any of these pathways explicitly involve skeletal muscle, the principal organ responsible for glucose disposal (6) and energy homeostasis (7), key processes that can impact the core pathogenesis of a systemic metabolic disease such as NAFLD (8).”
BackgroundSearching for the link between inflammaging and sarcopenia
Wang, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101611 · Cited by 98
Insulin resistance in patients with cancer: a systematic review and meta-analysis
Màrmol, J. M., Carlsson, M., Raun, S. H., Grand, M. K., Sørensen, J., Lehrskov, L. L., Richter, E. A., Norgaard, O., & Sylow, L. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2197124 · Cited by 104
“Insulin resistance increases the risk of developing type 2 diabetes [9] because insulin is the major hormone responsible for maintaining glycemic control by increasing glucose uptake into peripheral tissues while inhibiting hepatic glucose production [35].”
BackgroundMethodDynapenic obesity and the risk of incident Type 2 diabetes: the english longitudinal study of ageing
Cuthbertson, D. J., Bell, J. A., Ng, S. Y., Kemp, G. J., Kivimaki, M., & Hamer, M. (2016) · Diabetic Medicine · doi:10.1111/dme.12991 · Cited by 86
Norouzi, S., Adulcikas, J., Sohal, S. S., & Myers, S. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0394-0 · Cited by 92
“Insulin resistance (IR) is a common pathophysiological condition in which patients present with reduced insulin sensitivity and thus glucose intolerance, particularly in liver, adipose tissue and skeletal muscle [1].”
Shen, S., Liao, Q., Zhang, T., Pan, R., & Lin, L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14802 · Cited by 86
“Thus, skeletal muscle insulin resistance is considered to be the primary defect of insulin action (DeFronzo & Tripathy, 2009).”
BackgroundLinoleic acid and the regulation of glucose homeostasis: A review of the evidence
Hamilton, J., & Klett, E. L. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102366 · Cited by 95
Agarwal, P., Srivastava, R., Srivastava, R., Ali, S., & Datta, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.021 · Cited by 93
“Of the insulin target tissues, skeletal muscle insulin resistance is believed to be an early event during the onset and progression to diabetes [5].”
Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance
Hanssen, M. J. W., Wierts, R., Hoeks, J., Gemmink, A., Brans, B. T., Mottaghy, F. M., Schrauwen, P., & Lichtenbelt, W. D. V. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3465-8 · Cited by 93
“As a result, glucose uptake is reduced in peripheral tissues – mainly skeletal muscle, which is responsible for ∼80% of glucose uptake under insulinstimulated conditions, such as during a hyperinsulinaemic– euglycaemic clamp [20].”
BackgroundThe functional significance of the skeletal muscle clock: lessons from Bmal1 knockout models
Schiaffino, S., Blaauw, B., & Dyar, K. A. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0107-5 · Cited by 84
Mesinovic, J., Fyfe, J. J., Talevski, J., Wheeler, M. J., Leung, G. K. W., George, E. S., Hunegnaw, M. T., Glavas, C., Jansons, P., Daly, R. M., et al. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0112 · Cited by 114
“Studies have shown that both IMAT and specific IMCL species are positively associated with skeletal muscle insulin resistance [29-35], a key defect in T2DM [36].”
BackgroundPhysical Inactivity, Obesity, and Type 2 Diabetes: An Evolutionary Perspective
Eaton, S. B., & Eaton, S. B. (2017) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2016.1268519 · Cited by 108
An, K. O., & Kim, J. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.07.005 · Cited by 81
Møller, A. B., Kampmann, U., Hedegaard, J., Thorsen, K., Nordentoft, I., Vendelbo, M. H., Møller, N., & Jessen, N. (2017) · Scientific Reports · doi:10.1038/srep43775 · Cited by 82
Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044284 · Cited by 80
“Similarly, in hyperglycemic individuals skeletal muscle insulin sensitivity of glucose uptake is also poor [16].”
BackgroundWilliamson, A., Norris, D. M., Yin, X., Broadaway, K. A., Moxley, A. H., Vadlamudi, S., Wilson, E. P., Jackson, A. U., Ahuja, V., Andersen, M. K., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01408-9 · Cited by 80
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.